跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LACTIFENCE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LACTIFENCE
Authorized
STANDARD
LACTIFENCE
Delaval Inc.
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
bc56f90c6e0b05fd
Company
Delaval Inc.
Type
Standard
Approval Details
Approval Id
bc56f90c6e0b05fd
Drug Approval Canada Name
LACTIFENCE
Product Name
LACTIFENCE
Status
Marketed
Status Date
2018-02-06
Original Market Date
2018-02-06
Din
02461978
Drug Class
Veterinary
Dosage Form
Solution
Route Of Administration
Topical
Schedule
NON-PRESCRIPTION DRUGS
Atc Original
Not Applicable
Aig Number
0108801010
Company Name
Delaval Inc.
Company Address
10900 Rue Secant Street Ville D'Anjou Quebec Canada H1J 1S5
Company Detail Path
/organization/delaval-inc
Company Information
Pharmaceutical Company Name
Delaval Inc.
Country Name
United States
Province Name
Missouri
City Name
kansas city,missouri,country_us
Address
11100 N Congress Ave
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
bc56f90c6e0b05fd
Type
Standard
Back to Health Canada Approvals